Medscape Gastroenterology Podcast

New guidelines from IDSA/SHEA highlight best practices for treating C difficile infection. Dr David Johnson provides insight for all providers who must be cognizant of this widespread problem.

Researchers have revised the understanding of microbiota's effect on neurodegeneration and have proposed a new word to describe it: mapranosis.

Dr Kuchay discusses his findings from the E-LIFT study.

Dr David Johnson on the continued high value of this readily available technology.

Dr David J. Kerr discusses the difficult task of delivering bad news to patients--and their often paradoxical response--by sharing one of his favorite poems by Raymond Carver

Dr David Kerr on how combining ploidy and stroma-tumor fraction can guide treatment decisions in patients with stage II disease.

Irreproducible results published in journals are misleading, irresponsible, and costly, and it is up to researchers and publishers to resolve this problem now.

Dr David Johnson on how to follow up initial discovery to determine whether what you're dealing with is benign, life-threatening, or something in between.

Dr David Johnson provides clinicians with an overview of the new guidelines from the American Association for the Study of Liver Diseases (AASLD) on hepatocellular carcinoma.

Dr David Kerr on the latest setback from this once promising therapy.